Control of anticoagulant therapy.
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D011517:Prothrombin Time; D011786:Quality Control; D013925:Thromboplastin / Q000138:chemical synthesis
D000925:Anticoagulants; D013925:Thromboplastin